Validation of dot blot hybridization and denaturing high performance liquid chromatography as reliable methods for TP53 codon 72 genotyping in molecular epidemiologic studies

BMC Genetics

Volumn 11, Issue , 2010, Pages

  Rabachini, Tatiana ^a,b,c,d   Trottier, Helen ^e,f   Franco, Eduardo L ^e   Villa, Luisa L ^a,b  

^a LUDWIG INSTITUTE FOR CANCER RESEARCH   (Brazil)

^b HOSPITAL ALEMÃO OSWALDO CRUZ   (Brazil)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

^d McGill University ^*  (Brazil)

^e MCGILL UNIVERSITY   (Canada)

^f UNIVERSITY OF MONTREAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

ARTICLE; CODON; CONDYLOMA ACUMINATUM; CONTROLLED STUDY; DENATURING HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; DOT HYBRIDIZATION; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MOLECULAR EPIDEMIOLOGY; RELIABILITY; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; UTERINE CERVIX CANCER; VALIDATION STUDY; DNA DENATURATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IMMUNOBLOTTING; METHODOLOGY; NUCLEIC ACID HYBRIDIZATION; TUMOR SUPPRESSOR GENE;

CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CODON; FEMALE; GENES, P53; GENOTYPE; HUMANS; IMMUNOBLOTTING; MOLECULAR EPIDEMIOLOGY; NUCLEIC ACID DENATURATION; NUCLEIC ACID HYBRIDIZATION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH;

EID: 77952657493     PISSN: None     EISSN: 14712156     Source Type: Journal    
DOI: 10.1186/1471-2156-11-44     Document Type: Article

References (16)

1. Soussi T, Beroud C. Assessing TP53 status in human tumours to evaluate clinical outcome. Nat Rev Cancer 2001, 1:233-40. 10.1038/35106009, 11902578.
2. Feng Z, Hu W, Rajagopal G, Levine AJ. The tumor suppressor p53: cancer and aging. Cell Cycle 2008, 7:842-7.
3. Whibley C, Pharoah PD, Hollstein M. p53 polymorphisms: cancer implications. Nat Rev Cancer 2009, 2:95-107.
4. Dumont P, Leu JI, Della Pietra AC, George DL, Murphy M. The codon 72 polymorphic variants of p53 have markedly different apoptotic potential. Nat Genet 2003, 33:357-65. 10.1038/ng1093, 12567188.
5. Siddique M, Sabapathy K. Trp53-dependent DNA-repair is affected by the codon 72 polymorphism. Oncogene 2006, 25:3489-500. 10.1038/sj.onc.1209405, 16462765.
6. Thomas M, Kalita A, Labrecque S, Pim D, Banks L, Matlashewski G. Two polymorphic variants of wild-type p53 differ biochemically and biologically. Mol Cell Biol 1999, 19:1092-100. 116039, 9891044.
7. Storey A, Thomas M, Kalita A, Harwood C, Gardiol D, Mantovani F, Breuer J, Leigh IM, Matlashewski G, Banks L. Role of a p53 polymorphism in the development of human papillomavirus-associated cancer. Nature 1998, 393:229-34. 10.1038/30400, 9607760.
8. Koushik A, Platt RW, Franco EL. p53 codon 72 polymorphism and cervical neoplasia: a meta-analysis review. Cancer Epidemiol Biomarkers Prev 2004, 13:11-22. 10.1158/1055-9965.EPI-083-3, 14744727.
9. Cox DG, Kraft P. Quantification of the power of Hardy-Weinberg equilibrium testing to detect genotyping error. Hum Hered 2006, 61:10-4. 10.1159/000091787, 16514241.
10. Shi MM, Bleavins MR, de la iglesia FA. Technologies for detecting genetic polymorphisms in pharmacogenomics. Mol Diagn 1999, 4:343-51. 10.1016/S1084-8592(99)80011-3, 10671645.
11. Weber JL. Human DNA polymorphisms and methods of analysis. Curr Opin Biotechnol 1990, 1:166-71. 10.1016/0958-1669(90)90026-H, 1367853.
12. Frueh FW, Noyer-Weidner M. The use of denaturing high-performance liquid chromatography (DHPLC) for the analysis of genetic variations: impact for diagnostics and pharmacogenetics. Clin Chem Lab Med 2003, 41:452-61. 10.1515/CCLM.2003.068, 12747586.
13. Franco E, Villa L, Rohan T, Ferenczy A, Petzl-Erler M, Matlashewski G. Design and methods of the Ludwig-McGill longitudinal study of the natural history of human papillomavirus infection and cervical neoplasia in Brazil. Ludwig-McGill Study Group. Rev Panam Salud Publica 1999, 6:223-33. 10.1590/S1020-49891999000900001, 10572472.
14. Gorina S, Pavletich NP. Structure of the p53 tumor suppressor bound to the ankyrin and SH3 domains of 53BP2. Science 1996, 274:1001-5. 10.1126/science.274.5289.1001, 8875926.
15. D'Aquila RT, Bechtel LJ, Videler JA, Eron JJ, Gorczyca P, Kaplan JC. Maximizing sensitivity and specificity of PCR by pre-amplification heating. Nucleic Acids Res 1991, 19:3749. 10.1093/nar/19.13.3749, 328414, 1852616.
16. Sanguinetti CJ, Dias Neto E, Simpson AJ. Rapid silver staining and recovery of PCR products separated on polyacrylamide gels. Biotechniques 1994, 17:914-21.